{"transactions":[{"id":689966,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of Axogen Inc. common stock underlying the stock option grant will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate stock options vest on March 1, 2025 (24 months from the grant date) and an additional 12.5% of the aggregate stock options vest each 6 months thereafter."}],"balance_after":22500,"derivative":{"exercise_price":8.16,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":689965,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":67500,"price":47.345,"value":3195787.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.16 to $47.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50135,"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":689964,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-08-12T20:13:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":67500,"price":8.16,"value":550800.0,"ownership":{"direct":true},"balance_after":117635,"source":{"system":"sec-edgar","filing":"0000805928-26-000099","document":"wk-form4_1786565598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/wk-form4_1786565598.xml","form_type":"4"}},{"id":875711,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"All shares of Axogen, Inc. common stock underlying the RSUs will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"All shares of Axogen, Inc. common stock underlying the RSUs will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."}],"balance_after":11250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875710,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the RSUs will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"All shares of Axogen Inc. common stock underlying the RSUs will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":23000,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875709,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4427,"price":30.65,"value":135687.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of RSUs."}],"balance_after":50135,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875708,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This reflects the number of restricted stock units (\"RSUs\")  that vested on March 1, 2026."}],"balance_after":54562,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875707,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8753,"price":31.9,"value":279220.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's  Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units (\"PSUs\")."}],"balance_after":43312,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":875706,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-02T23:15:48.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":33780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria."}],"balance_after":52065,"source":{"system":"sec-edgar","filing":"0000805928-26-000042","document":"wk-form4_1772493346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000042/wk-form4_1772493346.xml","form_type":"4"}},{"id":972065,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-12T21:05:58.000Z","date":"2025-12-11","kind":"sale","planned":false,"acquired":false,"shares":13222,"price":30,"value":396660.0,"ownership":{"direct":true},"balance_after":18285,"source":{"system":"sec-edgar","filing":"0000805928-25-000170","document":"wk-form4_1765573554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000170/wk-form4_1765573554.xml","form_type":"4"}},{"id":975258,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-10T22:19:43.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":9278,"price":31.208,"value":289547.824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025 in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":31507,"source":{"system":"sec-edgar","filing":"0000805928-25-000162","document":"wk-form4_1765405180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000162/wk-form4_1765405180.xml","form_type":"4"}},{"id":979703,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-12-05T21:56:18.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares issued upon the attainment of certain performance criteria."}],"balance_after":40785,"source":{"system":"sec-edgar","filing":"0000805928-25-000151","document":"wk-form4_1764971775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000151/wk-form4_1764971775.xml","form_type":"4"}},{"id":1191656,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-26T20:47:11.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 25, 2029 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 25, 2027 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 25, 2029 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 25, 2027 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":55000,"derivative":{"underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000805928-25-000044","document":"wk-form4_1743022024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000044/wk-form4_1743022024.xml","form_type":"4"}},{"id":1224733,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-03-05T23:24:23.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares of Axogen, Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"All shares of Axogen, Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 based on a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025, and an additional 25% of the aggregate shares vest each twelve months thereafter. Vested shares will be delivered to the Reporting Person upon the vesting date. The RSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)."}],"balance_after":22500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000805928-25-000035","document":"wk-form4_1741217056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000035/wk-form4_1741217056.xml","form_type":"4"}},{"id":1224732,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T23:24:23.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":5901,"price":18.36,"value":108342.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on March 1, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on March 4, 2025 in multiple transactions at prices ranging from $18.34 to $18.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":18285,"source":{"system":"sec-edgar","filing":"0000805928-25-000035","document":"wk-form4_1741217056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000035/wk-form4_1741217056.xml","form_type":"4"}},{"id":1224731,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T23:24:23.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on March 1, 2025."}],"balance_after":24186,"source":{"system":"sec-edgar","filing":"0000805928-25-000035","document":"wk-form4_1741217056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000035/wk-form4_1741217056.xml","form_type":"4"}},{"id":1244477,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-02-26T21:24:16.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":814,"price":16.5,"value":13431.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units (\"PSUs\") on February 22, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on February 25, 2025 in multiple transactions at prices ranging from $16.42 to $17.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1686,"source":{"system":"sec-edgar","filing":"0000805928-25-000019","document":"wk-form4_1740605048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000019/wk-form4_1740605048.xml","form_type":"4"}},{"id":1244476,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-02-26T21:24:16.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares issued upon the attainment of certain performance criteria."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0000805928-25-000019","document":"wk-form4_1740605048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000019/wk-form4_1740605048.xml","form_type":"4"}},{"id":1623747,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Performance Stock Units","published_at":"2024-02-23T21:00:59.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":68600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the performance stock units (\"PSUs\") granted to the reporting person pursuant to the Issuer's Amended and Restated 2019 Long-Term Incentive Plan (\"Plan\") in respect of calendar year 2024. Each PSU represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three-year performance period beginning February 22, 2024 and ending February 22, 2027, subject to the reporting person's continuous service through the end of such performance period. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person and subject to availability under the Plan, the number of PSUs earned could range from 0% to 200% of such target number."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the performance stock units (\"PSUs\") granted to the reporting person pursuant to the Issuer's Amended and Restated 2019 Long-Term Incentive Plan (\"Plan\") in respect of calendar year 2024. Each PSU represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three-year performance period beginning February 22, 2024 and ending February 22, 2027, subject to the reporting person's continuous service through the end of such performance period. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person and subject to availability under the Plan, the number of PSUs earned could range from 0% to 200% of such target number."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the performance stock units (\"PSUs\") granted to the reporting person pursuant to the Issuer's Amended and Restated 2019 Long-Term Incentive Plan (\"Plan\") in respect of calendar year 2024. Each PSU represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three-year performance period beginning February 22, 2024 and ending February 22, 2027, subject to the reporting person's continuous service through the end of such performance period. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person and subject to availability under the Plan, the number of PSUs earned could range from 0% to 200% of such target number."}],"balance_after":68600,"derivative":{"underlying":"Common Stock","underlying_shares":68600},"source":{"system":"sec-edgar","filing":"0001209191-24-003887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000120919124003887/doc4.xml","form_type":"4"}},{"id":2076401,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Perf ormance Stock Units","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":24029,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"kind","element":"transactionCoding","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":24029},"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2076400,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Perf ormance Stock Units","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":24029,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"kind","element":"transactionCoding","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each award of restricted stock units with vesting subject to performance-based conditions (\"Company PSU Award\") outstanding immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of December 22, 2022 (the \"Closing Date\") and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as of the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance) and"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"(B) the Cash Amount, and (ii) one CVR for each Issuer Share underlying such Company PSU Award (assuming (1) the actual level of performance for performance metrics for which the relevant performance period has been completed as of the Closing Date and (2) the maximum level of performance under the terms of the applicable award agreement as in effect on the date of the Merger Agreement for performance metrics for which the relevant performance period has not been completed as the Closing Date (subject, in the case of Company PSU Awards granted to the Chief Executive Officer of the Company, to a maximum level of performance of 200% of the target level of performance))."}],"balance_after":24029,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":24029},"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2076399,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":2961,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"kind","element":"transactionCoding","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":283.88,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":2961},"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2076398,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":5125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"kind","element":"transactionCoding","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":223.9,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":5125},"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2076397,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"kind","element":"transactionCoding","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each option to purchase Issuer Shares that was outstanding and unexercised immediately prior to the Effective Time was canceled and converted into the right to receive: (1) with respect to each stock option with a per share exercise price less than the Cash Amount (an \"In-the-Money Option\"), (A) an amount in cash, without interest, equal to the product of (I) the aggregate number of Issuer Shares underlying such In-the-Money Option and (II) the excess, if any, of (x) the Cash Amount over (y) the per share exercise price of such In-the-Money Option and (B) one CVR per Issuer Share underlying such In-the-Money Option; and"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(2) with respect to each stock option with a per share exercise price that was greater than or equal to the Cash Amount (an \"Out-of-the-Money option\"), upon each Valuation Point (as defined in the Merger Agreement) occurring after the Effective Time, an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Out-of-the-Money Option and (B) (I) the excess, if any, of (x) the Per Share Value Paid (as defined in the Merger Agreement) as of such Valuation Point over (y) the per share exercise price of such Out-of-the-Money Option, less (II) the amount of all payments previously received with respect to such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":266.39,"expiration_date":"2029-05-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2076396,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-12-27T17:46:21.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":12237,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the effective time of the Merger (the \"Effective Time\") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (the \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the effective time of the Merger (the \"Effective Time\") was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share underlying such Company RSU Award immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-013011","document":"form4-12272022_101212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013011/form4-12272022_101212.xml","form_type":"4"}},{"id":2122876,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-11-08T16:34:22.000Z","date":"2022-11-05","kind":"tax_withholding","acquired":false,"shares":1548,"price":373.99,"value":578936.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":12237,"source":{"system":"sec-edgar","filing":"0001415889-22-011186","document":"form4-11082022_091107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922011186/form4-11082022_091107.xml","form_type":"4"}},{"id":2122875,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-11-08T16:34:22.000Z","date":"2022-11-04","kind":"sale","acquired":false,"shares":2000,"price":373.71,"value":747420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the sale price of the transactions on the reported date at $373.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":13785,"source":{"system":"sec-edgar","filing":"0001415889-22-011186","document":"form4-11082022_091107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922011186/form4-11082022_091107.xml","form_type":"4"}},{"id":2171216,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-08-30T16:34:48.000Z","date":"2022-08-29","kind":"sale","acquired":false,"shares":500,"price":255.95,"value":127975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the sale price of the transactions on the reported date at $259.9500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":15785,"source":{"system":"sec-edgar","filing":"0001415889-22-009176","document":"form4-08302022_010837.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922009176/form4-08302022_010837.xml","form_type":"4"}},{"id":2252194,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-31T17:31:25.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":480,"price":266.34,"value":127843.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":16285,"source":{"system":"sec-edgar","filing":"0001415889-22-005932","document":"form4-05312022_020511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005932/form4-05312022_020511.xml","form_type":"4"}},{"id":2252193,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-05-31T17:31:25.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":976,"price":266.34,"value":259947.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":16765,"source":{"system":"sec-edgar","filing":"0001415889-22-005932","document":"form4-05312022_020511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005932/form4-05312022_020511.xml","form_type":"4"}},{"id":2252192,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $.01 par value","published_at":"2022-05-31T17:31:25.000Z","date":"2022-05-29","kind":"grant","acquired":true,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 29, 2020. One hundred percent of these restricted stock units vested on May 29, 2022 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 29, 2020. One hundred percent of these restricted stock units vested on May 29, 2022 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone."}],"balance_after":17741,"source":{"system":"sec-edgar","filing":"0001415889-22-005932","document":"form4-05312022_020511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005932/form4-05312022_020511.xml","form_type":"4"}},{"id":2252191,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $.01 par value","published_at":"2022-05-31T17:31:25.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":4680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 26, 2023, May 26, 2024 and May 26, 2025, so long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 26, 2023, May 26, 2024 and May 26, 2025, so long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":15541,"source":{"system":"sec-edgar","filing":"0001415889-22-005932","document":"form4-05312022_020511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005932/form4-05312022_020511.xml","form_type":"4"}},{"id":2254552,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & GENERAL COUNSEL"}}],"security":"Common Stock, $.01 par value","published_at":"2022-05-27T16:09:13.000Z","date":"2022-05-25","kind":"tax_withholding","acquired":false,"shares":298,"price":249.19,"value":74258.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":10861,"source":{"system":"sec-edgar","filing":"0001415889-22-005797","document":"form4-05272022_010551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922005797/form4-05272022_010551.xml","form_type":"4"}},{"id":2520571,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-11-09T16:06:07.000Z","date":"2021-11-06","kind":"tax_withholding","acquired":false,"shares":152,"price":361.71,"value":54979.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":11159,"source":{"system":"sec-edgar","filing":"0001179110-21-009978","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009978/edgar.xml","form_type":"4"}},{"id":2523880,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-11-05T16:29:43.000Z","date":"2021-11-03","kind":"tax_withholding","acquired":false,"shares":1549,"price":349.76,"value":541778.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":11311,"source":{"system":"sec-edgar","filing":"0001179110-21-009902","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009902/edgar.xml","form_type":"4"}},{"id":2523879,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-11-05T16:29:43.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":6975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":12860,"source":{"system":"sec-edgar","filing":"0001179110-21-009902","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021009902/edgar.xml","form_type":"4"}},{"id":2625397,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-07-26T17:12:01.000Z","date":"2021-07-23","kind":"tax_withholding","acquired":false,"shares":106,"price":323.54,"value":34295.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":5885,"source":{"system":"sec-edgar","filing":"0001179110-21-007660","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021007660/edgar.xml","form_type":"4"}},{"id":2687836,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-06-02T16:46:38.000Z","date":"2021-05-29","kind":"tax_withholding","acquired":false,"shares":480,"price":284.58,"value":136598.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":5991,"source":{"system":"sec-edgar","filing":"0001179110-21-006232","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006232/edgar.xml","form_type":"4"}},{"id":2694299,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-27T16:44:42.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":2961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6."}],"balance_after":2961,"derivative":{"exercise_price":283.88,"exercise_date":"2022-05-25","expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":2961},"source":{"system":"sec-edgar","filing":"0001179110-21-006012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006012/edgar.xml","form_type":"4"}},{"id":2694298,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-05-27T16:44:42.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25, 2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25, 2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates."}],"balance_after":6471,"source":{"system":"sec-edgar","filing":"0001179110-21-006012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021006012/edgar.xml","form_type":"4"}},{"id":2987414,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":24363,"kind":"person","name":"Began Marc A","position":1,"cik":"0001821352","reported_name":"Began Marc A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & General Counsel"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-11-10T16:30:50.000Z","date":"2020-11-06","kind":"tax_withholding","acquired":false,"shares":153,"price":272.4,"value":41677.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":4471,"source":{"system":"sec-edgar","filing":"0001179110-20-010972","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020010972/edgar.xml","form_type":"4"}}]}